In this episode of the Active Ingredients podcast, host Thomas Dove interviews Gabriel Morelli, Global Freelance Consultant, Advisor and Certified Mentor and Coach.
Gabriel Morelli has spent over 25 years in life sciences, spanning generics, CDMOs, consulting and private equity-backed organisations. His career began in Montevideo, was redirected by a British Council scholarship MBA at Cranfield, and has since evolved into an independent advisory practice across the pharma value chain.
In this conversation, he explains why most generics and CDMO companies chase the wrong metrics, how to assess a new role within 90 days, and why the freelance leap demands more preparation than most executives expect.
Key Takeaways
• Learn why integrity, curiosity and genuine interest in people are Gabriel's three non-negotiable leadership qualities, shaped across generics, CDMOs and private equity.
• Discover how the systemic view of commercial excellence separates strong generics and CDMO businesses from those that optimise one element while quietly failing everywhere else.
• Understand why private equity operates by different rules from corporate life, and why more than half of senior hires struggle once the armies of support are gone.
• Explore Gabriel's 90-day rule for assessing whether you can succeed in a new role, and why acting on an honest answer early signals clarity rather than weakness.
• Apply the planning principles behind a credible freelance advisory career: a defined niche, consulting skills and commercial fitness before leaving corporate employment.
• Gain a clearer view of idea diversity and why teams built around genuine intellectual friction produce stronger outcomes than diversity defined by demographics alone.
• Identify why the value most senior executives believe they carry is tied to their company and title, and why most discover this too late to act.
• Uncover how Gabriel grew from 5,000 to 22,000 LinkedIn followers through daily publishing, and why a consistent point of view wins more advisory work than any CV.
• Take away why adaptability will define the next generation of life science leaders as geopolitics, technology and talent continue to accelerate.
Snippets
• “The moment you feel that you will not be successful, just push the eject button, disappear, and, focus on something else.”
• “It doesn’t really matter if you do something great downstream. If upstream, you’re doing everything wrong… it’s better to do everything average than to be great at KPIs.”
• “I’m not so fixated on the diversity, equity and inclusion… To me, what is important is, is ideas… You want people with different ideas with some tensions, some friction, but it needs to be operational.”
Timestamps & Topics
The following timestamps are approximations:
• [00:00] –– Intro: Gabriel Morelli’s career across generics, CDMOs, consulting and private equity
• [04:14] –– Career Origins: From Montevideo to Cranfield and the MBA that led to life sciences
• [18:47] –– Commercial Strategy: The systemic gap in commercial excellence across generics and CDMOs
• [21:59] –– Private Equity: Cash discipline, no place to hide, and why most corporate hires struggle
• [29:20] –– Quit Fast: The 90-day rule and why staying for appearances is the wrong move
• [35:29] –– Second Wave: Defining a niche and why LinkedIn replaces traditional business development
Resources
• Follow Gabriel Morelli on LinkedIn: https://www.linkedin.com/in/morelligabriel/
• Follow Thomas Dove on LinkedIn: https://www.linkedin.com/in/lifesciencesexecutivesearch/
Don't Miss an Episode
Sign up to the Active Ingredients podcast at www.activeingredients.fraserdove.com.
Remember to tune into our next episode for more inspiring insights. You can also subscribe to the Active Ingredients podcast on Apple Podcasts, Amazon, Spotify, YouTube and other leading podcast platforms.
Loved this episode?
Share it with your friends, family, or your peers!
